Covista Inc

Covista Inc(CVSA)股票分析

$131.820

+0.198 (+0.15%)收盤時

Loading chart…
最高
132.580
開盤
131.230
成交量加權均價
131.71
成交量
250.02K
市值
—
最低
130.735
成交金額
32.93M
企業價值/稅息折舊攤銷前利潤(TTM)
9.69

Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.

AI 分析 of Covista Inc (CVSA)

持有

Covista Inc is currently a hold. The stock is priced at $126.75, which is below the average analyst price target of $145, indicating potential upside. However, the RSI is at 44.605, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The forward P/E ratio of 13.6054 is attractive, indicating reasonable valuation, but recent insider selling raises caution. The main risk is the recent insider sales, with the CEO selling shares worth approximately $690,000, which could signal caution among executives.

估值指標

Covista Inc(CVSA)目前預期本益比為 13.61,5 年平均預期本益比為 14.35。

預期本益比

合理
5 年均值 P/E
14.35
目前P/E
13.61
高估
15.69
低估
13.01

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
9.47
目前EV/EBITDA
9.69
高估
10.18
低估
8.75

預期股價營收比

合理
5 年均值 P/S
1.98
目前P/S
2.00
高估
2.10
低估
1.86

持有 CVSA 的大戶

Ö

ÖKoworld Lux S.A.

+ 持有CVSA

+2.46%

3個月報酬率

A

Ariel Investments, LLC

+ 持有CVSA

-4.55%

3個月報酬率

事件時間軸

2026-09-15 (ET)

09:30:00

Covista Invests $150,000 in THC to Expand Healthcare Career Exploration

2026-09-14 (ET)

08:30:00

Chamberlain University Appoints Jason Dunne as Chief Academic Officer

2026-08-06 (ET)

17:30:00

Covista Q4 Revenue of $501.4M Exceeds Expectations

17:30:00

Sees FY27 Revenue at $2.05B-$2.09B

2026-07-28 (ET)

08:30:00

Covista Appoints Emily Chiu and Leslie Storms to Board of Directors

資訊

CVSA 常見問題 —— 由 Alphio AI 解答

Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership. It operates in the Academic & Educational Services sector.

Covista Inc is currently a hold. The stock is priced at $126.75, which is below the average analyst price target of $145, indicating potential upside. However, the RSI is at 44.605, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The forward P/E ratio of 13.6054 is attractive, indicating reasonable valuation, but recent insider selling raises caution. The main risk is the recent insider sales, with the CEO selling shares worth approximately $690,000, which could signal caution among executives.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易